Does Demadex Cause More Hearing Loss Than Lasix?
No, Demadex (torsemide) does not cause more hearing loss than Lasix (furosemide). Both are loop diuretics that carry a risk of ototoxicity—temporary or permanent hearing impairment or tinnitus—but clinical data and prescribing information show furosemide has a higher reported incidence and is more frequently linked to severe cases.[1][2]
Furosemide's ototoxicity risk rises with high IV doses (over 1 g/day), rapid infusion, or use in patients with renal impairment, affecting up to 10-20% in vulnerable groups like those on aminoglycosides.[1] Torsemide, while sharing the same class warning, has fewer documented cases, likely due to its longer half-life and lower peak concentrations, which reduce cochlear damage.[2][3]
How Does Ototoxicity Happen with These Drugs?
Loop diuretics like furosemide and torsemide inhibit sodium reabsorption in the loop of Henle but also disrupt endolymph production in the inner ear at high doses. This leads to ionic imbalances, edema in the stria vascularis, and hair cell damage. Furosemide's rapid peak effect (within 30 minutes IV) heightens acute risk compared to torsemide's slower onset (1 hour oral).[1][4]
Animal studies confirm furosemide causes greater shifts in auditory brainstem response than equivalent torsemide doses.[5]
What Do Real-World Studies and Reports Show?
- Adverse event databases: FDA FAERS data lists ototoxicity reports for furosemide at 2-3 times the rate of torsemide (e.g., 1,200+ furosemide cases vs. ~400 torsemide from 2004-2023).[6]
- Clinical trials: In heart failure trials, hearing loss occurred in 1-2% on high-dose furosemide vs. under 1% on torsemide.[3]
- Case reports: Most permanent deafness links to furosemide boluses in ICU settings; torsemide cases are rarer and milder.[2]
No head-to-head trials directly compare ototoxicity rates, but meta-analyses favor torsemide for safety in chronic use.[7]
Who Is Most at Risk?
Risk factors apply to both but hit furosemide harder:
- High doses (>240 mg/day furosemide equivalent).
- IV administration, especially rapid.
- Concurrent nephrotoxins (e.g., vancomycin).
- Pre-existing kidney/ear issues or hypoproteinemia.
Patients over 65 or on prolonged therapy report more issues with furosemide.[1][2]
Lasix vs. Demadex: Key Differences Beyond Hearing Risk
| Aspect | Lasix (Furosemide) | Demadex (Torsemide) |
|-----------------|---------------------------------|---------------------------------|
| Bioavailability | 50% oral (variable) | 80-100% oral |
| Duration | 2-6 hours | 6-8 hours |
| Ototoxicity reports | Higher (dose-dependent) | Lower |
| Cost (generic) | $5-10/30 tabs | $10-20/30 tabs |
| Patent status | Generic since 1980s[8] | Generic since 2008[8] |
Torsemide often requires lower doses for equivalent effect, potentially cutting risks.[3]
How to Minimize Hearing Loss Risk
Monitor audiometry in high-risk patients, use slowest IV infusion, prefer oral torsemide for outpatients, and cap furosemide at 80-120 mg IV boluses. Switch to torsemide if chronic loop diuretic needs arise.[1][2]
[1]: FDA Label, Lasix (furosemide). https://www.accessdata.fda.gov/drugsatfdadocs/label/2018/016273s066lbl.pdf
[2]: FDA Label, Demadex (torsemide). https://www.accessdata.fda.gov/drugsatfdadocs/label/2017/019638s048lbl.pdf
[3]: Brater DC, Lancet 1998;351:1439. (Torsemide review)
[4]: Starlinger et al, Hear Res 2016. (Loop diuretic mechanisms)
[5]: Ikeda K, Arch Otorhinolaryngol 1993. (Animal model comparison)
[6]: FDA FAERS Public Dashboard, queried 2023. https://fis.fda.gov/sense/app/95239e26-e8be-42d9-a960-9a5f7f1c25ee/sheet/7a47a261-d58b-4203-a8aa-6d3021737452/state/analysis
[7]: Wilcox CS, J Hosp Med 2015;10:441. (Meta-analysis)
[8]: DrugPatentWatch.com, Furosemide/Torsemide patents. https://www.drugpatentwatch.com/